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SUMMARY – Th e study included 60 patients with multiple sclerosis (MS) hospitalized at 
our institution from September 1 to December 31, 2014. Th e aim of the study was to assess the 
prevalence of restless legs syndrome (RLS) in MS patients and RLS relationship with patient age, 
sex, degree of disability, form of MS, time elapsed from MS diagnosis and use of antidepressants. Th e 
diagnosis of RLS was made according to the criteria set by the International Restless Legs Syndrome 
Study Group. Of the 60 patients, 24 (40%) met the criteria for the existence of RLS. In the group of 
patients with RLS, there was a signifi cantly higher proportion of women and those that were taking 
antidepressants. Th ere were no statistically signifi cant between-group diff erences according to age, 
duration of illness, degree of disability and clinical course of MS. In the study, 37.5% of patients that 
met the criteria for RLS diagnosis had not informed the neurologists about their diffi  culties. Th e 
high prevalence of RLS and the fact that a large proportion of patients did not inform the neurologists 
about their diffi  culties related to RLS point to the need of an active approach to diagnosis and 
 treatment.
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Introduction
Restless legs syndrome (RLS) is a common move-
ment disorder with prevalence in the general popula-
tion between 4% and 29%1. Th e syndrome is character-
ized by an urge to move the legs, usually accompanied 
or caused by unpleasant sensations in the legs that 
 begin or worsen during a period of rest or inactivity. 
Th e symptoms are partially or totally relieved by mo-
vement and occur or worsen in the evening or night. 
Th e RLS diagnosis is established according to the In-
ternational Restless Legs Syndrome Study Group 
(IRLSSG) criteria2. RLS can be idiopathic or due to 
secondary causes. Secondary RLS is associated with 
various pathological conditions such as iron defi ciency, 
peripheral neuropathy, Parkinson’s disease, essential 
tremor, renal failure, spinocerebellar ataxias, myelopa-
thies, and myasthenia gravis3-9. Although the patho-
physiology remains unclear, brain iron defi ciency and 
dysfunctions of the dopaminergic system seem to play 
an important role10.
Available research suggests the RLS prevalence in 
multiple sclerosis (MS) patients to be higher as com-
pared with the general population11-14. Although the 
true reason for this is not known, cervical cord damage 
was found to be associated with a higher prevalence of 
RLS in MS patients15. Th e prevalence of idiopathic 
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RLS in Croatia is 9.5%16. In this study, we investigated 
RLS prevalence in MS patients.
Patients and Methods
Th is study analyzed the RLS prevalence in patients 
with MS that underwent inpatient rehabilitation at 
the Lipik Special Hospital for Medical Rehabilitation 
from September 1 to December 31, 2014. In addition, 
current antidepressant medication was also analyzed. 
Th e study included patients older than 18 and diag-
nosed with MS according to the revised McDonald 
criteria17.
Exclusion criteria were serious cognitive damage, 
recent infectious illness, or other acute complication in 
the previous 3 months. Based on the exclusion criteria, 
four patients were not enrolled in the study. Th e fol-
lowing data were collected on each patient: age, gen-
der, MS course, time elapsed from MS diagnosis, pres-
ence of RLS, use of antidepressants, and whether they 
informed the attending neurologist about their feeling 
of leg restlessness.
Th e RLS diagnosis was established using the 
IRLSSG criteria2. Th e level of incapacity was deter-
mined in each patient based on the Expanded Disabil-
ity Status Scale (EDSS) score18, whereas assessment of 
the cognitive status was performed using the Mini 
Mental Status19. Th e study was approved by the Hos-
pital Ethics Committee, and a written consent for par-
ticipation was obtained from the patients.
Statistical analysis was done using the SOFA Stats. 
Comparison of variables was performed using the Stu-
dent’s t-test and Pearson’s correlation test.
Results
Th e study included 60 subjects, 37 (61.7%) women 
and 23 (38.3%) men, mean age 49.5 (range, 29-71) 
years. Th e mean time elapsed from MS diagnosis was 
12.2 years (range, 6 months to 32 years). Th e mean 
EDSS was 4.9 (range of 1.5-9). Seventeen (28.3%) pa-
tients were taking antidepressant medication. Th irty 
(50%) patients had the relapsing-remitting (RRMS) 
and the remaining 30 (50%) patients had the second-
ary progressive (SPMS) course of the disease.
Twenty-four (40%) study patients fulfi lled the 
clinical criteria for the presence of RLS. Characteris-
tics of MS patients with and without RLS are sum-
marized in Table 1. Th ere was no signifi cant diff erence 
between the groups with and without RLS according 
to age (p=0.255), while the prevalence of RLS was sig-
nifi cantly higher in women (p=0.011).
Th ere were no signifi cant diff erences between the 
RLS positive and RLS negative groups in the global 
values of EDSS (p=0.735) and the time elapsed from 
MS diagnosis (p=0.564).
Antidepressant intake was signifi cantly higher in 
the RLS positive group (p=0.043).
Th e distribution of RLS prevalence was equal in 
the two MS clinical courses present in our patients 
(p=1.000) (Fig. 1). Nine (37.5%) of the 24 RLS posi-
tive patients did not inform the attending neurologist 
about their feeling of leg restlessness.
Table 1. Characteristics of patients with and without 
restless legs syndrome





























RLS = restless legs syndrome; MS = multiple sclerosis
RRMS = relapsing-remitting multiple sclerosis; 
SPMS = secondary progressive multiple sclerosis
Fig. 1. Distribution of the prevalence of restless legs 
syndrome (RLS) in 2 clinical courses of multiple sclerosis.
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Discussion
In our study, RLS prevalence in MS patients was 
40%. Th e estimated RLS prevalence in MS patients 
varies widely. A meta-analysis that included 24 studies, 
conducted in 201211, showed that RLS prevalence in 
MS patients ranged from 12.1% to 57.5%. In the stud-
ies published after the aforementioned meta-analysis, 
the estimated RLS prevalence in patients with MS 
varied from 14.5% to 65.1 %12-14. Th e variation of RLS 
prevalence in general population is due to diff erences 
in demographic factors, health status and study popu-
lations1. Heterogeneity is also present in the studies 
that investigated RLS prevalence in patients with MS, 
which could explain diff erences in the estimated prev-
alence among the studies11. Pooled analysis performed 
in the meta-analysis by Schürsk and Bussfeld11 indi-
cates that MS is associated with a fourfold increase in 
the odds for RLS compared with people without MS. 
Th is is in concordance with our survey, since the esti-
mated prevalence of the idiopathic form of RLS in 
Croatia is 9.5%16.
In the present study, there was no age diff erence 
between the groups with and without RLS. Th e same 
fi ndings have been reported from most of other stud-
ies13,20-22.
Th e higher prevalence of RLS syndrome in women 
in our study may have refl ected the higher proportion 
of women with RLS in the general population1. Man-
coni et al. also found a higher prevalence of women in 
the RLS positive group5, although no gender diff er-
ences were recorded in other studies13,20-22. Th e time 
elapsed from MS diagnosis did not diff er between the 
RLS positive and RLS negative groups, which is also 
consistent with other studies13,14,20-22. Th ere was no as-
sociation between the EDSS score and presence of 
RLS either; however, we did fi nd positive association 
between the use of antidepressants and the prevalence 
of RLS. A higher use of antidepressants in the RLS 
positive group was recorded in the study by Manconi 
et al.5, but no such diff erence was found in the study by 
Shaygannejad et al.14. Considering that some antide-
pressants have the potential of causing RLS23,24, while 
others do not23,25, a diff erent medication regimen could 
explain, at least partly, the above mentioned diff erences 
among the studies.
Our subjects were suff ering from RRMS and 
SPMS, whereas the primary progressive (PPMS) 
course was not present. We found no signifi cant diff er-
ence in the prevalence of RLS in any clinical course. 
Comparable results have been reported by Miri et al.13 
and Morieira et al.21, whereas other studies demon-
strated an increased prevalence of RLS in patients 
with RRMS20 and PPMS20,22. Nine (37.5%) of the 24 
patients with RLS did not inform the neurologist 
about their leg restlessness.
Conclusion
In this study, RLS was present in 40% of MS pa-
tients. Th e presence of RLS was associated with female 
gender and use of antidepressants. More than one-
third of patients with RLS did not inform the neu-
rologist about their feeling restlessness in the legs. In a 
chronic debilitating disease such as MS, long-term 
preservation of the quality of life in terms of health 
should be considered as a critical marker of therapeutic 
success26. Due to the high prevalence of RLS in MS 
patients, there is the need to search actively for RLS 
symptoms.
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Sažetak
SINDROM NEMIRNIH NOGU KOD OBOLJELIH OD MULTIPLE SKLEROZE – ISKUSTVA BOLESNIKA 
LIJEČENIH U SPECIJALNOJ BOLNICI ZA MEDICINSKU REHABILITACIJU U LIPIKU
M. Časar Rovazdi, V. Vidović, O. Kraml i V. Bašić Kes
U studiji je obuhvaćeno 60 oboljelih od multiple skleroze (MS). Svi su bili hospitalizirani u našoj ustanovi od 1. rujna 
2014. do 31. prosinca 2014. Cilj rada je bio istražiti učestalost sindroma nemirnih nogu (RLS) i odrediti međusobnu pove-
zanost RLS-a s dobi ispitanika, spolom, stupnjem onesposobljenosti, oblikom MS, vremenom proteklim od postavljanja 
 dijagnoze MS i uzimanjem antidepresiva. Dijagnoza RLS-a postavljena je sukladno kriterijima Međunarodne studijske 
grupe za sindrom nemirnih nogu (IRLSSG). Od ukupno 60 ispitanika njih 24 (40%) ispunilo je kriterije za postojanje 
RLS-a. U skupini ispitanika s RLS utvrđena je statistički značajno veća zastupljenost žena i onih koji uzimaju antidepresive. 
Nije nađena statistički značajna razlika između skupina u odnosu na životnu dob, trajanje bolesti, stupanj onesposobljenosti 
i klinički tijek MS. Od 24 bolesnika koji su ispunili kriterije za dijagnozu RLS-a njih 37,5% nije obavijestilo neurologa o 
prisutnim smetnjama. Visoka učestalost RLS-a i činjenica da velik udio oboljelih ne iznosi nadležnom neurologu smetnje iz 
okvira RLS-a zahtijevaju aktivan pristup u dijagnostici i liječenju.
Ključne riječi: Multipla skleroza – epidemiologija; Sindrom nemirnih nogu – dijagnostika; Bolnice, specijalne; Hrvatska
